XML 74 R62.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Based Compensation - Omnibus Incentive Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
May 27, 2021
Dec. 31, 2022
Dec. 31, 2021
Weighted- Average Remaining Contractual Term (in Years)      
Balance (in years)   4 years 7 months 24 days 5 years 7 months 2 days
Granted (in years)   6 years 3 months 7 days  
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable   4 years 5 months 12 days  
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest   4 years 7 months 24 days  
Omnibus Plan | Stock Options      
Stock based compensation      
Number of additional shares authorized 1,000,000    
Number of shares available for grant 2,200,000 944,123  
Stock options granted (in shares)   44,905  
Stock option life (in years)   7 years  
Number of shares      
Balance at beginning of year (in shares)   778,835  
Granted (in shares)   44,905  
Exercised (in shares)   (28,752)  
Expired (in shares)   (1,320)  
Forfeited (in shares)   (13,045)  
Balance at end of year (in shares)   780,623 778,835
Options: Options vested and exercisable   680,564  
Options: Options vested and expected to vest   780,623  
Weighted-Average Exercise Price      
Balance at beginning of year (in dollars per share)   $ 18.02  
Granted (in dollars per share)   14.95  
Exercised (in dollars per share)   6.47  
Expired (in dollars per share)   21.75  
Forfeited (in dollars per share)   26.55  
Balance at end of year (in dollars per share)   18.12 $ 18.02
Weighted-Average Exercise Price: Options vested and exercisable   17.34  
Weighted-Average Exercise Price: Options vested and expected to vest   $ 18.12  
Number of unvested options scheduled to vest      
Non-Vested Options as of beginning of period   127,357  
Granted (in shares)   44,905  
Vested (in shares)   (59,158)  
Forfeited (in shares)   (13,045)  
Non-Vested Options as of end of period   100,059 127,357
Weighted-Average Grant Date Fair Value      
Non-Vested, beginning balance   $ 17.42  
Granted: Weighted-Average Grant Date Fair Value   8.99 $ 17.42
Vested: Weighted-Average Grant Date Fair Value   17.42  
Forfeited: Weighted-Average Grant Date Fair Value   15.68  
Non-Vested, ending balance   $ 6.02 $ 17.42
Valuation Assumptions:      
Expected term in years   4 years 3 months 4 years 3 months
Volatility (as a percent)   77.60% 78.60%
Risk-free interest rate   2.86% 0.71%
Dividend yield (as a percent)   0.00% 0.00%
Granted: Weighted-Average Grant Date Fair Value   $ 8.99 $ 17.42
Aggregate intrinsic value of stock option awards outstanding   $ 15,902  
Aggregate intrinsic value of stock option awards vested and exercisable   14,636  
Aggregate intrinsic value of stock option awards vested and expected to vest   15,902  
Intrinsic value of options exercised   414 $ 802
Total fair value of options vested   $ 1,031 $ 50
2021 | Omnibus Plan | Stock Options      
Number of unvested options scheduled to vest      
Non-Vested Options as of end of period   100,059  
Valuation Assumptions:      
Term of award   P7Y  
Vesting period   2 years